Chengfeng Qiu

578 total citations
24 papers, 416 citations indexed

About

Chengfeng Qiu is a scholar working on Surgery, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Chengfeng Qiu has authored 24 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 5 papers in Molecular Biology and 4 papers in Infectious Diseases. Recurrent topics in Chengfeng Qiu's work include Lipoproteins and Cardiovascular Health (6 papers), Cancer, Lipids, and Metabolism (3 papers) and HIV/AIDS drug development and treatment (3 papers). Chengfeng Qiu is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Cancer, Lipids, and Metabolism (3 papers) and HIV/AIDS drug development and treatment (3 papers). Chengfeng Qiu collaborates with scholars based in China, United Kingdom and United States. Chengfeng Qiu's co-authors include Xiang Zhao, Zhen Zhang, Quan Zhou, Mats Hillert, Zhihua Shi, Ziwei Deng, Feng Li, Jun Zhu, Ling Zhang and Haoyu Tang and has published in prestigious journals such as Scientific Reports, Hypertension and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Chengfeng Qiu

21 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengfeng Qiu China 11 118 109 51 49 42 24 416
Md Nahidul Islam Ireland 16 97 0.8× 168 1.5× 39 0.8× 42 0.9× 43 1.0× 42 604
Xiaomin Liu China 12 60 0.5× 116 1.1× 74 1.5× 55 1.1× 43 1.0× 33 572
César Ríos‐Navarro Spain 18 183 1.6× 171 1.6× 42 0.8× 30 0.6× 41 1.0× 77 781
Saif A. Muhsin United States 8 77 0.7× 126 1.2× 68 1.3× 25 0.5× 16 0.4× 13 500
Mohamed Egypt 13 93 0.8× 102 0.9× 24 0.5× 81 1.7× 56 1.3× 58 604
Weidong Lin China 15 73 0.6× 124 1.1× 64 1.3× 68 1.4× 48 1.1× 65 622
William C. Nahas Brazil 12 121 1.0× 100 0.9× 24 0.5× 44 0.9× 69 1.6× 64 450
Yongguo Li China 13 88 0.7× 144 1.3× 33 0.6× 54 1.1× 26 0.6× 33 368
Anatol Panasiuk Poland 12 82 0.7× 78 0.7× 25 0.5× 33 0.7× 31 0.7× 47 565
Yujie Zhou China 17 246 2.1× 114 1.0× 51 1.0× 87 1.8× 35 0.8× 62 723

Countries citing papers authored by Chengfeng Qiu

Since Specialization
Citations

This map shows the geographic impact of Chengfeng Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengfeng Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengfeng Qiu more than expected).

Fields of papers citing papers by Chengfeng Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengfeng Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengfeng Qiu. The network helps show where Chengfeng Qiu may publish in the future.

Co-authorship network of co-authors of Chengfeng Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Chengfeng Qiu. A scholar is included among the top collaborators of Chengfeng Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengfeng Qiu. Chengfeng Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Feng, et al.. (2025). Tryptophan metabolites as biomarkers to predict the severity and prognosis of acute ischemic stroke patients. Journal of Stroke and Cerebrovascular Diseases. 34(8). 108382–108382.
2.
Li, Yapei, Yapei Li, Yuyang Tian, et al.. (2024). Cathepsin L Promotes Pulmonary Hypertension via BMPR2/GSDME-Mediated Pyroptosis. Hypertension. 81(12). 2430–2443. 8 indexed citations
3.
4.
Yang, Xiaoxia, Huanhuan Li, Xiaodan Zeng, et al.. (2023). Improved LC–MS/MS method for the simultaneous quantification of tacrolimus and cyclosporine A in human blood and application to therapeutic drug monitoring. Biomedical Chromatography. 37(12). e5751–e5751.
5.
Deng, Ziwei, et al.. (2023). Elevated circulating PCSK9 level is associated with 28-day mortality in patients with sepsis: a prospective cohort study. BMC Emergency Medicine. 23(1). 127–127. 1 indexed citations
6.
Qiu, Chengfeng, et al.. (2021). Nursing intervention using healing touch in total knee replacement. Medicine. 100(3). e23735–e23735.
7.
8.
Deng, Ziwei, Hongqiang Wang, Yi Chen, et al.. (2021). Integrase inhibitors versus efavirenz combination antiretroviral therapies for TB/HIV coinfection: a meta-analysis of randomized controlled trials. AIDS Research and Therapy. 18(1). 25–25. 7 indexed citations
9.
Qiu, Chengfeng, Ziwei Deng, Qian Xiao, et al.. (2020). Transmission and clinical characteristics of coronavirus disease 2019 in 104 outside‐Wuhan patients, China. Journal of Medical Virology. 92(10). 2027–2035. 47 indexed citations
10.
Zhao, Xiang, Xing Luo, Zhihua Shi, et al.. (2020). Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trials. BMC Pharmacology and Toxicology. 21(1). 86–86. 9 indexed citations
11.
Zhao, Xiang, Zhihua Shi, Ziwei Deng, et al.. (2020). Asialoglycoprotein receptor 1 gene expression in peripheral blood monocytes associates with serum total cholesterol and low-density lipoprotein cholesterol levels. Chinese Medical Journal. 133(12). 1505–1506. 3 indexed citations
12.
Tan, Liming, Xi Li, Chengfeng Qiu, et al.. (2019). CLEC4M is associated with poor prognosis and promotes cisplatin resistance in NSCLC patients. Journal of Cancer. 10(25). 6374–6383. 12 indexed citations
13.
Qiu, Chengfeng, Xiang Zhao, Zhihua Shi, et al.. (2019). Baricitinib induces LDL-C and HDL-C increases in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Lipids in Health and Disease. 18(1). 54–54. 29 indexed citations
14.
Qiu, Chengfeng, Quan Zhou, Xiaohui Li, et al.. (2017). High circulating proprotein convertase subtilisin/Kexin type 9 concentration associates with cardiovascular risk. Medicine. 96(48). e8848–e8848. 10 indexed citations
15.
Qiu, Chengfeng, Pingyu Zeng, Xiaohui Li, et al.. (2017). What is the impact of PCSK9 rs505151 and rs11591147 polymorphisms on serum lipids level and cardiovascular risk: a meta-analysis. Lipids in Health and Disease. 16(1). 111–111. 35 indexed citations
16.
Tan, Liming, Chengfeng Qiu, Tao Zhu, et al.. (2017). Genetic Polymorphisms and Platinum-based Chemotherapy Treatment Outcomes in Patients with Non-Small Cell Lung Cancer: A Genetic Epidemiology Study Based Meta-analysis. Scientific Reports. 7(1). 5593–5593. 26 indexed citations
17.
Qiu, Chengfeng, Xiang Zhao, Quan Zhou, & Zhen Zhang. (2017). High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis. Lipids in Health and Disease. 16(1). 212–212. 67 indexed citations
18.
Zhu, Jun, Haoyu Tang, Zhenhua Zhang, et al.. (2016). Kaempferol slows intervertebral disc degeneration by modifying LPS-induced osteogenesis/adipogenesis imbalance and inflammation response in BMSCs. International Immunopharmacology. 43. 236–242. 73 indexed citations
19.
Zhi-gang, Zhao, Hongli Zhou, Yahong Peng, et al.. (2014). Expression and significance of plasma 3-NT and ox-LDL in patients with Alzheimer's disease. Genetics and Molecular Research. 13(4). 8428–8435. 16 indexed citations
20.
Valentin, Jean‐Pierre, et al.. (1995). Modulation of ANP-dependent effects of endothelin by inhibitors of neutral endopeptidase and cGMP phosphodiesterase.. Journal of Pharmacology and Experimental Therapeutics. 273(2). 744–752. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Md Nahidul Islam Breakdown of academic impact, for papers by Xiaomin Liu Breakdown of academic impact, for papers by César Ríos‐Navarro Breakdown of academic impact, for papers by Saif A. Muhsin Breakdown of academic impact, for papers by Mohamed Breakdown of academic impact, for papers by Weidong Lin Breakdown of academic impact, for papers by William C. Nahas Breakdown of academic impact, for papers by Yongguo Li Breakdown of academic impact, for papers by Anatol Panasiuk Breakdown of academic impact, for papers by Yujie Zhou
Rankless by CCL
2026